Healthtech funding in Q1 2025
European Healthtech startup funding raised during Q1 2025.
In Q1 2025, 112 European Healthtech companies closed 112 funding rounds and raised €2.5B in equity funding (excluding debt and grants), up 168.2% versus Q1 2024. UK led by capital raised, and Bayern Kapital was the most active investor. Data as of 20 Nov 2026.
Equity funding
€2.5B
+168.2% vs Q1 2024 · excl. debt & grants
Funding rounds
112
-9.7% vs Q1 2024
Companies
112
Top country
UK
Rank among sectors
#2
13.4% of sector funding
Top-10 round share
74.7%
of disclosed capital
Rounds ≥ €100M
6
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q1 2025 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €1.5B | 35 |
| Feb | €214M | 44 |
| Mar | €804M | 33 |
Top countries
by € raisedHealthtech — top countries by capital, Q1 2025 — interactive chart.
Data table
| Healthtech — top countries by capital, Q1 2025 | |
|---|---|
| UK | €1.3B |
| Sweden | €253M |
| Switzerland | €186M |
| Ireland | €178M |
| Denmark | €130M |
| France | €114M |
| Germany | €89M |
| Netherlands | €78M |
Stage mix
by € raisedHealthtech — stage mix, Q1 2025 — interactive chart.
Data table
| Healthtech — stage mix, Q1 2025 | |
|---|---|
| Other | €1.2B |
| Series A | €825M |
| Series B | €283M |
| Series C | €101M |
| Seed | €64M |
| Pre-Seed | €15M |
| Grant | €1.7M |
Exits & M&A
6 Acquisition6 exits.
Top deals
largest disclosed rounds in Q1 2025| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Other | Mar 2025 | €555M |
| Verdiva Bio | Series A | Jan 2025 | €399M |
| Neko Health | Series B | Jan 2025 | €250M |
| Cera | Other | Jan 2025 | €150M |
| CeQur | Other | Jan 2025 | €116M |
| Fire1 | Other | Jan 2025 | €115M |
| Orbis Medicines | Series A | Jan 2025 | €90M |
| Leyden Labs | Other | Jan 2025 | €68M |
| Maxion Therapeutics | Series A | Mar 2025 | €66M |
| Numab | Series C | Jan 2025 | €53M |
| Quibim | Series A | Jan 2025 | €50M |
| Coave Therapeutics | Series A | Jan 2025 | €32M |
| Deciphex | Series C | Jan 2025 | €31M |
| Avelios Medical | Series A | Feb 2025 | €30M |
| Germitec | Other | Feb 2025 | €29M |
Top investors
most active in Q1 2025, by deal count- Bayern Kapital4 deals
- High-Tech Gründerfonds (HTGF)4 deals
- Novo Holdings4 deals
- Forbion3 deals
- Foundation for Technological Innovation (FIT)3 deals
- LUMO labs3 deals
- UI Investissement3 deals
- Venture Kick3 deals
- ACF investors2 deals
- Almi Invest2 deals